Structural and Mechanistic Insights into Dual Deprotonation by an Engineered GPP Methyltransferase: Discovery of Methyltransferases Generating Noncanonical Prenyl Diphosphates
ACS Catalysis · 18.07.2025 · 15 (14) · 12351-12364
DOI: 10.1021/acscatal.5c03939 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Catalysis, online erschienen am 07.07.2025. Verfasst von Chenyang Xia und 9 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Wuhan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Key Research and Development Program of China
- Wuhan University
- National Natural Science Foundation of China
Zitieren
APA
Xia, C., Lu, B., Xu, Q., Shen, N., Liao, Q., Cui, J., Wang, B., Sun, Y., Dong, C., & Gan, F. (2025). Structural and Mechanistic Insights into Dual Deprotonation by an Engineered GPP Methyltransferase: Discovery of Methyltransferases Generating Noncanonical Prenyl Diphosphates. ACS Catalysis, 15(14), 12351-12364. https://doi.org/10.1021/acscatal.5c03939
Vancouver
Xia C, Lu B, Xu Q, Shen N, Liao Q, Cui J, et al. Structural and Mechanistic Insights into Dual Deprotonation by an Engineered GPP Methyltransferase: Discovery of Methyltransferases Generating Noncanonical Prenyl Diphosphates. ACS Catalysis. 2025;15(14):12351-12364. doi:10.1021/acscatal.5c03939
BibTeX
@article{Xia2025,
author = {Xia, Chenyang and Lu, Bowen and Xu, Qi and Shen, Nanxin and Liao, Qiancheng and Cui, Jiyun and Wang, Baiyang and Sun, Yueyang and Dong, Changjiang and Gan, Fei},
title = {Structural and Mechanistic Insights into Dual Deprotonation by an Engineered GPP Methyltransferase: Discovery of Methyltransferases Generating Noncanonical Prenyl Diphosphates},
journal = {ACS Catalysis},
year = {2025},
volume = {15},
number = {14},
pages = {12351--12364},
doi = {10.1021/acscatal.5c03939}
}
EUVIMED